GENinCode (LSE:GENI) Quick Ratio : 1.24 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is GENinCode Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. GENinCode's quick ratio for the quarter that ended in Dec. 2023 was 1.24.

GENinCode has a quick ratio of 1.24. It generally indicates good short-term financial strength.

The historical rank and industry rank for GENinCode's Quick Ratio or its related term are showing as below:

LSE:GENI' s Quick Ratio Range Over the Past 10 Years
Min: 0.42 Med: 3.99 Max: 18
Current: 1.24

During the past 5 years, GENinCode's highest Quick Ratio was 18.00. The lowest was 0.42. And the median was 3.99.

LSE:GENI's Quick Ratio is ranked worse than
68.42% of 228 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.89 vs LSE:GENI: 1.24

GENinCode Quick Ratio Historical Data

The historical data trend for GENinCode's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GENinCode Quick Ratio Chart

GENinCode Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Quick Ratio

0.42

3.99

18.00

4.80

1.24

GENinCode Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Quick Ratio	Get a 7-Day Free Trial			18.00	15.89	4.80	5.85	1.24

Competitive Comparison of GENinCode's Quick Ratio

For the Diagnostics & Research subindustry, GENinCode's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GENinCode's Quick Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GENinCode's Quick Ratio distribution charts can be found below:

* The bar in red indicates where GENinCode's Quick Ratio falls into.

GENinCode Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

GENinCode's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )	=	(Total Current Assets	-	Total Inventories)	/	Total Current Liabilities
	=	(3.192	-	0.084)	/	2.498
	=	1.24

GENinCode's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )	=	(Total Current Assets	-	Total Inventories)	/	Total Current Liabilities
	=	(3.192	-	0.084)	/	2.498
	=	1.24

GENinCode (LSE:GENI) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.

GENinCode Quick Ratio Related Terms

Thank you for viewing the detailed overview of GENinCode's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

GENinCode Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GENinCode PLC (LSE:GENI) » Definitions » Quick Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP

Website

https://www.genincode.com

GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment being sale of kits and provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain and United Kingdom.